Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,007 | 5,430 | 12,405 | 17,972 | 25,883 |
| Inventories | 1,879 | 1,243 | 138 | 169 | 516 |
| Other current assets | 894 | 1,504 | 2,490 | 715 | 1,305 |
| TOTAL | $7,128 | $8,385 | $15,755 | $20,266 | $28,848 |
| Non-Current Assets | |||||
| PPE Net | 44 | 34 | 10 | 18 | 23 |
| Intangibles | 37,159 | 39,201 | 39,282 | 40,489 | 35,761 |
| TOTAL | $37,202 | $39,235 | $39,292 | $40,507 | $35,784 |
| Total Assets | $44,330 | $47,620 | $55,046 | $60,773 | $64,632 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 538 | 3,496 | 28 | 2,435 | 1,838 |
| TOTAL | $3,069 | $5,473 | $3,745 | $5,085 | $4,920 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,069 | $5,473 | $3,745 | $5,085 | $4,920 |
| Shareholders' Equity | |||||
| Common Shares | 2,404 | 2,305 | 2,216 | 2,360 | 2,001 |
| Retained earnings | -120,271 | -113,274 | -99,036 | -104,419 | -76,965 |
| Other shareholders' equity | 38,719 | 37,273 | 36,029 | 38,366 | 38,484 |
| TOTAL | $41,261 | $42,147 | $51,302 | $55,687 | $59,711 |
| Total Liabilities And Equity | $44,330 | $47,620 | $55,046 | $60,773 | $64,632 |